StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Adamas Pharma (ADMS) Ramps Into the Close
December 23, 2015 3:38 PM
Adamas Pharma (NASDAQ: ADMS) ramps into ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Trader Talk
Next Articles
Adamas Pharmaceuticals (ADMS) PT Raised to $37 at Credit Suisse
December 24, 2015 7:37 AM
Adamas Pharmaceuticals (ADMS) PT Raised to $38 at Needham & Company
December 23, 2015 2:18 PM
Unusual 11 Mid-Day Movers 12/23: (ADMS) (MEMP) (SXE) Higher; (NWBO) (GBSN) (STEM) Lower
December 23, 2015 1:01 PM
Streetinsider.com's Hot Lunchtime Reads 12/23: (STEM) (ADMS) (LL) (CHK)
December 23, 2015 12:22 PM
Aegis Capital Reaffirms Adamas Pharma (ADMS) at 'Buy'; Dyskinesia Secondary Endpoint Also Seen as Key
December 23, 2015 12:04 PM
Pre-Open Stock Movers 12/23: (ADMS) (ROVI) (CELG) Higher; (GBSN) (BBBY) (MU) Lower (more...)
December 23, 2015 9:26 AM
Piper Jaffray Remains Bullish on Adamas Pharmaceuticals (ADMS)
December 23, 2015 9:12 AM
Adamas Pharma (ADMS) Announces Statistically Significant ADS-5102 Phase 3 EASE LID Data
December 23, 2015 6:20 AM
Adamas Announces Positive Top-Line Phase 3 Results of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson’s Disease
December 23, 2015 6:00 AM
